These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26168763)

  • 61. Expanding the reach of harm reduction in Thailand: experiences with a drug user-run drop-in centre.
    Kerr T; Hayashi K; Fairbairn N; Kaplan K; Suwannawong P; Zhang R; Wood E
    Int J Drug Policy; 2010 May; 21(3):255-8. PubMed ID: 19766474
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Casting light on harm reduction: introducing two instruments for analysing contradictions between harm reduction and 'non-harm reduction'.
    Jourdan M
    Int J Drug Policy; 2009 Nov; 20(6):514-20. PubMed ID: 19349155
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Australian governments' spending on preventing and responding to drug abuse should target the main sources of drug-related harm and the most cost-effective interventions.
    McDonald D
    Drug Alcohol Rev; 2011 Jan; 30(1):96-100. PubMed ID: 21219503
    [TBL] [Abstract][Full Text] [Related]  

  • 64. How and why AIDS changed drug policy in Switzerland.
    Somaini B; Grob P
    J Public Health Policy; 2012 Aug; 33(3):317-24. PubMed ID: 22895501
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Heroin-assisted treatment in Switzerland: a case study in policy change.
    Uchtenhagen A
    Addiction; 2010 Jan; 105(1):29-37. PubMed ID: 19922519
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The landscape of services for drug users in Yogyakarta, Indonesia.
    Morrison C; Kurniasih Y; Barton G
    Drug Alcohol Rev; 2012 Jan; 31(1):95-100. PubMed ID: 22141745
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Harm-reduction strategies weapon of choice in BC's battle with drug addiction.
    Kent H
    CMAJ; 1996 Sep; 155(5):571-3. PubMed ID: 8804264
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Drug abuse profile - patient delay, diagnosis delay and drug resistance pattern - among addict patients with tuberculosis.
    Shamaei M; Marjani M; Baghaei P; Chitsaz E; Rezaei Tabar E; Abrishami Z; Tabarsi P; Mansouri D; Masjedi MR
    Int J STD AIDS; 2009 May; 20(5):320-3. PubMed ID: 19386968
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The development of peer educator-based harm reduction programmes in Northern Vietnam.
    Walsh N; Gibbie TM; Higgs P
    Drug Alcohol Rev; 2008 Mar; 27(2):200-3. PubMed ID: 18264883
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Change in attitudes and knowledge of problem drug use and harm reduction among a community cohort in Kabul, Afghanistan.
    Todd CS; Stanekzai MR; Nasir A; Fiekert K; Orr MG; Strathdee SA; Vlahov D
    East Mediterr Health J; 2016 Jun; 22(3):183-92. PubMed ID: 27334075
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Harm reduction history, response, and current trends in Asia.
    Thomson N
    J Food Drug Anal; 2013 Dec; 21(4):S113-S116. PubMed ID: 25264414
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Opiate use, treatment, and harm reduction in Afghanistan: recent changes and future directions.
    Todd CS; Macdonald D; Khoshnood K; Mansoor GF; Eggerman M; Panter-Brick C
    Int J Drug Policy; 2012 Sep; 23(5):341-5. PubMed ID: 22717389
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Persian At-Risk Women and Barriers to Receiving HIV Services in Drug Treatment: First Report From Iran.
    Samiei M; Moradi A; Noori R; Aryanfard S; Rafiey H; Naranjiha H
    Int J High Risk Behav Addict; 2016 Jun; 5(2):e27488. PubMed ID: 27622170
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Harm reduction: a new perspective on substance abuse services.
    MacMaster SA
    Soc Work; 2004 Jul; 49(3):356-63. PubMed ID: 15281690
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Persian Gulf states outline regional approach to tackle cancer.
    Burki TK
    Lancet Oncol; 2012 Feb; 13(2):126. PubMed ID: 22403809
    [No Abstract]   [Full Text] [Related]  

  • 76. Harm Reduction: Not Dirty Words Any More.
    Ramprashad A; Burnett GM; Welsh C
    Psychiatr Clin North Am; 2022 Sep; 45(3):529-546. PubMed ID: 36055737
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Treatment of opium addiction in persian medicine: A review study.
    Kamali M; Kamali H; Doustmohammadi M; Sheikhbardsiri H; Moghadari M
    J Educ Health Promot; 2021; 10():157. PubMed ID: 34222532
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Assessing the impact of harm reduction programs on law enforcement in Southeast Asia: a description of a regional research methodology.
    Thomson N; Moore T; Crofts N
    Harm Reduct J; 2012 Jul; 9():23. PubMed ID: 22769050
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Defining and redefining harm reduction in the Lao context.
    Sychareun V; Hansana V; Phommachanh S; Somphet V; Phommavongsa P; Tenni B; Moore T; Crofts N
    Harm Reduct J; 2012 Jul; 9():28. PubMed ID: 22769736
    [TBL] [Abstract][Full Text] [Related]  

  • 80. SACHR: an example of an integrated, harm reduction drug treatment program.
    Majoor B; Rivera J
    J Subst Abuse Treat; 2003 Dec; 25(4):257-62. PubMed ID: 14693254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.